 uh... uh... uh... uh... uh... uh... the Indian Pharmaceutical Association for Organizing this Global Innovation Summit. The COVID-19 pandemic has brought the importance of the health care sector into a sharp focus whether it is lifestyle or medicines, medical technology or vaccines. Every aspect of health care has received global attention over the last two years. In this context, the Indian pharmaceutical industry has also reasoned to the challenge. The global trust earned by the Indian health care sector had led to India being called the pharmacy of the world in recent times. Employing nearly three million people and generating a trade surplus of about 13 billion dollars, the Indian pharma industry had been a key driver of her economic growth. The combination of high quality and quantity at affordable prices has generated immense interest in the Indian pharma sector around the world. Since 2014, the Indian health care sector has attracted over 12 billion dollars in foreign direct investment. And there is still potential for much more. Friends, our definition of wellness is not limited by physical boundaries. We believe in the well-being of the entire humankind. Sarve apisokhina santu, sarve santu niramaya. And we have shown this period to the whole world during the COVID-19 global pandemic. We exported life-saving medicines and medical equipments to over 150 countries during the initial phase of the pandemic. We have also exported more than 65 million doses of COVID vaccines to nearly 100 countries this year. Over the coming months, as we ramp up our vaccine production capacity, we will do much more. Friends, the importance of innovation had been reinforced in the COVID-19 era in all walks of life. The disruption forced us to reimagine for our lifestyles the way we think and we work. In the context of the Indian pharma sector too, the speed, scale and willingness to innovate had been truly impressive. For example, it is this spirit of innovation that led to India becoming a major producer and exporter of PPEs. And it is the same spirit of innovation that led to India being at the forefront of innovating, producing, administering and exporting COVID-19 vaccines. Friends, the same spirit of innovation is reflected in the staff being taken by the government to encourage growth in the pharma sector. Last month, the government has released a draft document outlining the policy, catalyzed research and development and innovation in the pharma-meditech sector in India. This policy reflects India's commitment to encourage R&D in pharmaceutical and medical devices. Our vision is to create an ecosystem for innovation that will make India leader in a drug discovery and innovation in medical devices. Our policy interventions are being made based on wide consultation with all stakeholders. We are sensitive to the industry demands on regulatory framework and are actively working in this direction. The industry has got a major boost through the production-linked incentive schemes worth over 30,000 crore rupees for the pharmaceutical and medical devices. Friends, the support of industry, the academic world and specially our talented youth is important. That is why we are encouraging collaboration between academia and industry. India has a large pool of scientists and technologies with the potential to take the industry to greater heights. This strength needs to be harnessed to discover and make in India. Friends, I also wish to highlight two areas which I want you to explore carefully. The first one relates to raw material requirements. While we have been fighting COVID-19, we found that this was one issue that needs much more attention. Today, when 1.3 billion people of India have taken it upon themselves to make India atmanirvar, we must think about ramping up domestic manufacturing of key ingredients for vaccine and medicines. This is one frontier that India has to conquer. I am sure that investors and innovators are keen to work together to overcome these challenges as well. The second area relates to India's traditional medicines. There is now significant and growing demand of these products in the international markets. This can be seen through the sharp rise in export of these products in the recent years. In 2021 alone, India exported harpal medicines worth over 1.5 billion dollars. The WHO is also working to set up its global center for traditional medicines in India. Can we think of more ways to popularize our traditional medicines in the line with global requirements, scientific standards, and based manufacturing practices? Friends, I invite you all to ideate in India, innovate in India, make in India, and make for the world. Discover your true strength and serve the world. We have the talent, resources, and ecosystem required for innovation and enterprise. Our rapid strides, our spirit of innovation, and the scale of our achievements in the pharma sector have been noticed by the world. This is the best time to move forward and scale new heights. I assure global and domestic industry leaders and stakeholders that India is committed to enhance the ecosystem for innovation. May this summit serve as a flagship event to strengthen the Indian pharmaceutical industry position in R&D and innovation. I once again congratulate the organizers and wish the deliberations during this two-day summit will be fruitful. Thank you. Thank you very much.